As you continue the critically important work of supporting our patients and frontline workers during the COVID-19 crisis, we are writing to urge you to include in the next stimulus package protections for the health care coverage of employees and employers impacted by this pandemic and the economic downturn that has followed.
Categories
- Access
- Actions
- Copay Accumulators
- Copay Assistance
- COVID-19
- Drug Costs
- Featured
- Federal Issues
- Health Insurance
- Health Policy
- ICER
- Issues
- Letters Submitted
- Letters Supported
- Medicaid
- Medicare
- Medicare Part D
- News
- Op-Ed
- Out of Pocket Costs
- Pharmacy Benefit Managers
- Podcast
- Press Releases
- QALY
- State Issues
- Step Therapy
- Terry's Hot Takes
- Value Frameworks
- Virtual Advocacy Chat
Tags
340B
Access to Care
Biden Administration
Cancer
chemo drugs
cms
Copay Accumulators
copay assistance
COVID-19 Vaccine
DPC
drug costs
drug discount programs
Drug Importation
Drug Manufacturing
Drug Pricing
drug rebate
Elizabeth Warren
fail first
Health Insurance
hospital bills
HR 3708
hsa
ICER
Imported Drugs
Insurance design
Joe Biden
Lupus
Medicaid
medicare Part B
medicare part D
Nonmedical Switching
open enrollment
out of
Out of Pocket Costs
Patient Access
Patients Assitance
PBM
pharmacy benefit managers
Preexisting Conditions
Price Transparency
Prior Authorization
QALY
Step Therapy
transparency
Value Framework